Skip to main content
OpenTrials

Clinical trial condition

Neoplasm, Residual

Explore clinical trials studying Neoplasm, Residual. Study availability and eligibility vary by location and protocol.

207 public trials 79 recruiting studies
Refine in advanced search Browse all conditions

Neoplasm, Residual trial results

Enrolling by invitation

VEN+IDAC vs IDAC in AML

NCT07537257

Conditions
AML (Acute Myelogenous Leukemia), Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Department of Hematology, Guangdong Second Provincial General Hospital Guangzhou, Guangdong, China
View Trial Details
Active, not recruiting

A PoC Study to Evaluate Treatments' Efficacy by Monitoring MRD Using ctDNA in HR-positive/HER2-negative EBC Population

NCT05708235

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • Complejo Hospitalario Universitario A Coruña (CHUAC) A Coruña, Spain
  • Hospital General Universitario Dr. Balmis Alicante, Spain
  • Hospital Marina Salud de Denia Alicante, Spain
  • Hospital Virgen de los Lirios Alicante, Spain
View all 41 locations
View Trial Details
Active, not recruiting

Venetoclax + Azacitidine in Patients With Acute Myeloid Leukemia

NCT06668558

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • University Hospital Son Espases Palma de Mallorca, Balearic Islands, Spain
  • Hospital Son Llatzer Palma de Mallorca, Balearic Islands, Spain
  • Institut Catala D oncologia Badalona Badalona, Catalonia, Spain
  • Hospital Del Mar Barcelona, Catalonia, Spain
View all 14 locations
View Trial Details
Active, not recruiting

Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease

NCT03516279

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, +15 more
Locations
  • Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • CTCA at Western Regional Medical Center Goodyear, Arizona, United States
  • Cancer Center at Saint Joseph's Phoenix, Arizona, United States
  • Mercy Hospital Fort Smith Fort Smith, Arkansas, United States
View all 291 locations
View Trial Details
Active, not recruiting

Circulating Tumor DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II-III

NCT07821333

Conditions
Circulating Tumor Cell, Colonic Diseases, Colonic Neoplasms, +17 more
Locations
  • Hospital Universitario de Bellvitge L'Hospitalet de Llobregat, Barcelona, Spain
  • Hospital del Mar Barcelona, Spain
  • Hospital Universitari Vall D'Hebron Barcelona, Spain
  • Hospital Universitario Reina Sofía Córdoba, Spain
View Trial Details

Related conditions